ages 6 to 11 are safe and effective. while saying they ll seek emergency authorization from the fda soon. it shows that that smaller dose is still sufficient for younger kids. that it creates just as strong, if not stronger of an antibody response with potentially fewer side effects because your body is being exposed to less of the immunogenic material. reporter: the fda prepares to refew pfizer s smaller dose vaccines for kids as young as 5 tomorrow. shots in arms could come in the next two weeks. it s entirely possible, if not very likely that vaccines will be available for children from 5 to 11 within the first week or two of november. halloween comes even sooner. that s not causing much concern for health officials. i would say put on those costumes. stay outside and enjoy your trick-or-treating. reporter: passionate pleas for more people to get vaccinated. no one likes to be ordered to. but if you can get vaccinated and think of someone else, think
CNN The Lead With Jake Tapper October 25, 2021 20:17:15
archive.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archive.org Daily Mail and Mail on Sunday newspapers.
headed here now, that there will be a recommendation for the most vulnerable to get a booster? i think so, you know, we have had this discussion before, jim, we said that the two mrna vaccines will be three dose vaccines and joinhnson & johnso will be a two-dose vaccine. i said that early on where it showed that individuals who got two doses of the j&j vaccine had much higher levels of virus neutralizing antibody and more robust t-cell responses. and i think that s what s panning out. there was some discussion a couple of days ago about a preprint that came online suggesting that those who got a j&j dose of this irvaccine when they were when they got boosted with mrna vaccines they did better than a second j&j dose. i m pushing back a little bit on that in the sense that when you look at that early data, the big rise in responses were delayed happened later on, maybe 70, 80
specific targeted booster that elicits a response against those new variants. that hasn t happened yet but, there is a great deal of let s just say, ample discussion, that it s likely to occur at some point down the road. in that sense, it will be similar to meet needing a new flu shot periodically because your immune system no longer recognizes the form of influence and that s now in circulation. yeah, that s what i was about to say. that begins to sound like the flu shot process that we ve all grown accustomed to, which is annual. you know, the thing lawrence that i cannot underscore strongly enough, is, long before we get to the point of having vaccines for small children, adequate supplies a vaccine for the world, and third dose vaccines for us here in the united states, we are in a huge surge in the united
it is the next step in this. once they ve changed the authorization which right now is for two shots then the cdc has to vote on that and make a recommendation about whether or not to follow that authorization from the fda. and conveniently the cdc does have a meeting with its vaccine advisers scheduled for friday, and so there could be a vote coming out of that. so you could see this start to move quickly for some of these immunocompromised people waiting to hear from the fda and cdc whether or not they need a third shot of these two dose vaccines. what about boostersr for the general population? is this kind of just a first step so it s not everybody all at once? reporter: they re kind of considering two different things here. for people who are immune yo compromised concern they need a third shot is because they never developed a response to the vaccine that someone who is not
vimarsana © 2020. All Rights Reserved.